Alpine Bank Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Alpine Bank Wealth Management's BMY Position: Q1 2026 in Review
Alpine Bank Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.86% in Q1 2026, selling an estimated $5.01K and leaving 9,896 shares worth $600K. The position accounts for 0.09% of the portfolio, ranked #104.
Alpine Bank Wealth Management first reported a position in BMY in Q3 2024 and has held it in 6 quarters since. The position peaked at $678K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Alpine Bank Wealth Management held 9,896 shares of Bristol-Myers Squibb worth $600K as of Q1 2026.
- Alpine Bank Wealth Management sold 86 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.01K.
- Bristol-Myers Squibb made up 0.09% of Alpine Bank Wealth Management's portfolio in Q1 2026, its #104 holding.
- Alpine Bank Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 6 quarters since.
- Alpine Bank Wealth Management's Bristol-Myers Squibb position peaked at $678K in Q1 2025.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Alpine Bank Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.